The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Goli Samimi, Sumitra Ananda et al.|Nature Communications|2019Cited by 191
Therapeutic options for mucinous ovarian carcinomaKylie L. Gorringe, Clare L. Scott, Dane Cheasley et al.|Gynecologic Oncology|2020Cited by 95
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, P. Mackenzie, Dane Cheasley et al.|Modern Pathology|2020Cited by 43